From 20–22 January 2026, WHO Member States resumed negotiations on the Pathogen Access and Benefit-Sharing system (PABS), an annex to the WHO Pandemic Agreement. Discussions used draft text to narrow unresolved differences and identify emerging consensus; further sessions are planned, with the negotiating group’s outcome scheduled for consideration at the 79th World Health Assembly in May 2026.[1]
PABS is intended to enable secure, transparent, and responsible exchange of pathogens with pandemic potential and their genetic information, while ensuring equitable access to benefits derived from their use, including vaccines, treatments, and diagnostic tests.[1] For the Ark, this establishes a potential Earth-wide interface for genomic surveillance, countermeasure development, and benefit allocation—but its value depends on rapid access, trusted data provenance, biosafety controls, and continuity during geopolitical or infrastructure collapse.
The Ark team should monitor the negotiating sessions and the May 2026 World Health Assembly decision, then map the final PABS obligations against Ark protocols for pathogen genome archives, diagnostic validation, vaccine and therapeutic precursor stocks, and independent biosafety review. Any lunar biosecurity plan should preserve legally usable pathogen data, maintain offline reference libraries, and support countermeasure development without requiring uninterrupted terrestrial connectivity.